eMedicine Specialties > Thoracic Surgery > Vascular

Subclavian Artery Thrombosis

Author: Mary C Mancini, MD, PhD, Director of Cardiothoracic Transplantation, Professor, Department of Surgery, Louisiana State University Health Sciences Center
Contributor Information and Disclosures

Updated: Jan 15, 2008

Introduction

Subclavian artery thrombosis is a condition in which the blood flow through the vessel is obstructed. The condition usually occurs secondary to some form of antecedent injury to the vessel, hypercoagulable state, or atherosclerotic changes. The condition is common in young athletic individuals who exert a significant amount of upper body activity. Sudden occlusion from emboli followed by thrombosis of the artery is common in the population with signs of significant atherosclerotic disease.

The patient presenting with acute subclavian artery occlusion usually has a history of repetitive use and/or stress injury to the upper extremity on the affected side. A history of upper extremity claudication is common.

In situations in which the occlusion is secondary to atherosclerosis, acute thromboses of the artery are generally asymptomatic. In fact, in 9% of autopsy series, the left subclavian artery was either stenotic or occluded. If symptoms are present, upper extremity claudication on the affected side is most common. The patient may also present with dizziness, vertigo, imbalance, visual disturbances, or hemisensory dysfunction indicative of a subclavian steal syndrome. However, note that subclavian steal is observed on 2% of cerebral angiograms and causes no symptoms.

Problem

The occlusion arises secondary to damage to the intima of the artery. This damage can occur as a result of external muscular compression and repetitive stress to the artery or because of atherosclerotic changes to the vessel. Embolic phenomena and hypercoagulable states are also contributing factors.

Symptoms occur secondary to lack of blood flow to the affected extremity. To maintain blood supply to the extremity, blood is naturally rerouted from the vertebral, carotid, and internal mammary arteries, producing the various steal syndromes.

Frequency

Symptomatic lesions occur in less than 1% of the population. In autopsy series, 9% of the population demonstrate stenosis or occlusion of one subclavian artery, usually on the left. Two percent of cerebral angiograms demonstrate asymptomatic subclavian steal.

Etiology

The occlusion arises secondary to damage to the intima of the artery. This damage can occur as a result of external muscular compression and repetitive stress to the artery, atherosclerotic changes to the vessel, or inflammatory processes.

Embolic or thrombotic occlusion of the artery occurs, particularly in the presence of atherosclerotic stenoses. Hypercoagulable states contribute to this scenario.

Pathophysiology

The affected artery demonstrates detectable intimal damage, which is usually secondary to compressive forces exerted by the muscles of the shoulder girdle that compress the artery. Bony abnormalities in this area can also contribute to the process. As these muscles enlarge secondary to physical activity, they exert pressure on the artery. This pressure, coupled with exertional activity of the upper extremity, can stretch and compress the intima, thus disrupting its natural integrity. This disruption precipitates platelet deposition in the area, with resulting thrombosis.

Atherosclerotic changes in the vessel occur secondary to the flow characteristics in the area. These depositions are accelerated by all of the dietary and sociological influences that affect the progression of atherosclerotic disease, including smoking, hypercholesterolemia, and hypertension. Occlusion secondary to atherosclerosis is more insidious and often causes no symptoms. At times, the symptom complex of claudication precedes the actual loss of blood flow.

Patients with hypercoagulable states, either intrinsic or secondary to dehydration complicated by concomitant cardiac arrhythmias and systemic inflammatory processes, comprise a small subset of individuals who may exhibit this pathology.

Presentation

A patient with an acute occlusion presents with a cold, painful, pulseless upper extremity. Axillary, brachial, and radial pulses are generally absent. When the occlusion is secondary to atherosclerotic changes, various prodromes and manifestations may be observed.

The patient may present with no symptoms or upper extremity claudication secondary to exertion. If the condition has precipitated a steal syndrome, no symptoms are typically present. The examining physician should be aware of the rare presentation of various neurological symptoms and findings that may be associated with the steal syndromes, including syncope, vertigo, ataxia, sensory loss, visual changes, and stroke, depending on the vessels involved in the steal. The affected upper extremity may or may not demonstrate diminished pulses. Blood pressure differences between the affected and unaffected sides may be noted.

Indications

Therapeutic intervention is indicated in any symptomatic patient once the etiology of the symptoms has been defined. For instances of upper extremity claudication or acute thrombosis in which the problem has been attributed to the subclavian artery, intervention should be planned and executed. For patients in whom cerebrovascular symptoms predominate, a careful neurological evaluation must be undertaken in order to isolate the problem. Once the anatomical aberration has been defined, intervention is indicated if the subclavian artery is involved.

Relevant Anatomy

In patients with subclavian artery occlusion secondary to variations in the thoracic outlet, 2 areas can undergo vascular compression during hyperabduction of the extremity. One site is where the axillary artery passes posterior to the pectoralis minor muscle and beneath the coracoid process. The other point is where the artery courses between the clavicle and the first rib. Fibrous tissue proliferation in this area can impose extrinsic compression on the vessel.

Aberrant origins of the subclavian artery off the aortic arch can be a cause of subclavian artery occlusion.

In atherosclerotic disease, the carotid-subclavian junction or carotid-vertebral junctions are areas that appear to be predisposed to atheromata formation and calcification. Subsequently, this region is most likely to be involved in the occlusive process.

Areas of the subclavian artery that are exposed to repeated forms of injury resulting in intimal damage are predisposed to occlusion.

Contraindications

Contraindications to surgical intervention include inadequate distal runoff, inadequate vessel size, and marked collateralization of the occluded area. Concomitant medical problems that would endanger the patient during a surgical intervention are also contraindications to surgery. With the advent of stenting, patients with greater medical challenges can be treated successfully; however, the presence of appropriate arterial runoff and adequate artery size are imperative in order to ensure success of the procedure.

More on Subclavian Artery Thrombosis

Overview: Subclavian Artery Thrombosis
Workup: Subclavian Artery Thrombosis
Treatment: Subclavian Artery Thrombosis
Follow-up: Subclavian Artery Thrombosis
Multimedia: Subclavian Artery Thrombosis
References

References

  1. Baraki H, Hagl C, Khaladj N, Kallenbach K, Weidemann J, Haverich A. The frozen elephant trunk technique for treatment of thoracic aortic aneurysms. Ann Thorac Surg. Feb 2007;83(2):S819-23; discussion S824-31. [Medline].

  2. Boas N, Desmoucelle F, Bernadet V, Franceschi JC. Rare cause of acute ischemia of the right upper extremity: thrombosis of a retroesophageal subclavian artery. Ann Vasc Surg. May 2002;16(3):387-90. [Medline].

  3. Dave B, Bhatt N, Gupta M, Khalasi Y, Balasubramanya KS. Subclavian artery thrombosis--management with thrombolysis and angioplasty. J Indian Med Assoc. Sep 2004;102(9):519-20, 527. [Medline].

  4. Edwards WH. An unsuspected cause for recurrent angina: subclavian artery stenosis. Am Surg. Dec 1995;61(12):1057-60. [Medline].

  5. Fan Z, Roedersheimer R, Lohr J. Systemic thrombolysis using tissue plasminogen activator for a patient with paradoxic embolism: a case report. Vasc Endovascular Surg. Apr-May 2007;41(2):136-9. [Medline].

  6. Golcman L, Berginer VM, Szendro G, Hoda J, Louson Z. Prominent somnolence and cerebellar syndrome in subclavian artery thrombosis--a case report. Angiology. Dec 1987;38(12):912-5. [Medline].

  7. Hay E, Cohen H, Pasik S. Acute thrombosis of subclavian artery during CPR. Ann Emerg Med. Apr 1987;16(4):447-51. [Medline].

  8. Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviú MJ, Gennari L. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Am J Hematol. Aug 2004;76(4):330-7. [Medline].

  9. Henry M, Amor M, Henry I. Percutaneous transluminal angioplasty of the subclavian arteries. J Endovasc Surg. Feb 1999;6(1):33-41. [Medline].

  10. Hood DB, Kuehne J, Yellin AE, Weaver FA. Vascular complications of thoracic outlet syndrome. Am Surg. Oct 1997;63(10):913-7. [Medline].

  11. Laitt RD, Thompson JF, Goddard P, Wakeley CJ, Murphy P, Lamont P. Subclavian artery aneurysm: the role of magnetic resonance imaging. Cardiovasc Surg. Oct 1994;2(5):612-4. [Medline].

  12. Mandalam KR, Rao VR, Gupta AK, Joseph S, Unni NM, Rao AS. Occlusion of an aberrant right subclavian artery arising from a Kommerel diverticulum. J Vasc Interv Radiol. Jul-Aug 1993;4(4):577-9. [Medline].

  13. Mendelsohn AM, Buzzard CJ, Lerner NB, Ling FS. Transumbilical balloon angioplasty of subclavian artery thrombosis in a neonate. Catheter Cardiovasc Interv. Jan 2000;49(1):56-60. [Medline].

  14. Nehler MR, Taylor LM Jr, Moneta GL, Porter JM. Upper extremity ischemia from subclavian artery aneurysm caused by bony abnormalities of the thoracic outlet. Arch Surg. May 1997;132(5):527-32. [Medline].

  15. Nuber GW, McCarthy WJ, Yao JS, Schafer MF, Suker JR. Arterial abnormalities of the shoulder in athletes. Am J Sports Med. Sep-Oct 1990;18(5):514-9. [Medline].

  16. Rapp JH, Reilly LM, Goldstone J, Krupski WC, Ehrenfeld WK, Stoney RJ. Ischemia of the upper extremity: significance of proximal arterial disease. Am J Surg. Jul 1986;152(1):122-6. [Medline].

  17. Riesenman PJ, Farber MA, Mendes RR, Marston WA, Fulton JJ, Keagy BA. Coverage of the left subclavian artery during thoracic endovascular aortic repair. J Vasc Surg. Jan 2007;45(1):90-4; discussion 94-5. [Medline].

  18. Rogers JH, Calhoun RF 2nd. Diagnosis and management of subclavian artery stenosis prior to coronary artery bypass grafting in the current era. J Card Surg. Jan-Feb 2007;22(1):20-5. [Medline].

  19. Thompson JF, Webster JH. First rib resection for vascular complications of thoracic outlet syndrome. Br J Surg. May 1990;77(5):555-7. [Medline].

  20. Tyagi S, Rangasetty UC, Kaul UA. Stenting of a large thrombus-containing subclavian artery stenosis using a distal protection device. Indian Heart J. May-Jun 2003;55(3):262-4. [Medline].

  21. Vanherweghem JL, Cabolet P, Dhaene M, Goldman M, Stolear JC, Sabot JP. Complications related to subclavian catheters for hemodialysis. Report and review. Am J Nephrol. 1986;6(5):339-45. [Medline].

  22. Witz M, Lehman J, Shnaker A, Korzets Z. Acute subclavian and brachial artery thrombosis as a complication of the nephrotic syndrome. Isr Med Assoc J. Jul 2004;6(7):441-2. [Medline].

  23. Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol. Jun 2000;64(2):137-9. [Medline].

  24. Zeller T, Frank U, Bürgelin K, Sinn L, Horn B, Roskamm H. Acute thrombotic subclavian artery occlusion treated with a new rotational thrombectomy device. J Endovasc Ther. Dec 2002;9(6):917-21. [Medline].

  25. Zimmerman NB. Occlusive vascular disorders of the upper extremity. Hand Clin. Feb 1993;9(1):139-50. [Medline].

Further Reading

Keywords

subclavian artery thrombosis, subclavian artery occlusion, subclavian steal syndrome, cerebral steal syndrome, thoracic outlet syndrome, atherosclerosis, atherosclerotic disease, muscular compartment syndromes, hypercoagulable states, subclavian vein thrombosis, catheter-directed thrombolytic therapy, angioplasty, stents, stenting

Contributor Information and Disclosures

Author

Mary C Mancini, MD, PhD, Director of Cardiothoracic Transplantation, Professor, Department of Surgery, Louisiana State University Health Sciences Center
Mary C Mancini, MD, PhD is a member of the following medical societies: American Heart Association, American Medical Association, American Thoracic Society, Association for Academic Surgery, Association for Surgical Education, International College of Surgeons, International Society for Heart and Lung Transplantation, New York Academy of Sciences, Phi Beta Kappa, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey Lawrence Kaufman, MD, Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine
Jeffrey Lawrence Kaufman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society for Artificial Internal Organs, Association for Academic Surgery, Association for Surgical Education, Massachusetts Medical Society, Phi Beta Kappa, and Society for Vascular Surgery
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Daniel S Schwartz, MD, FACS, Clinical Assistant Professor of Cardiothoracic Surgery, New York University School of Medicine; Consulting Staff, Department of Surgery, Division of Thoracic Surgery, North Shore University Hospital/Long Island Jewish Medical Center
Daniel S Schwartz, MD, FACS is a member of the following medical societies: American Association for the Advancement of Science, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Diabetes Association, American Heart Association, American Medical Association, Association for Academic Surgery, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other; AMGEN Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.